These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease. Wong CR; Nguyen MH; Lim JK World J Gastroenterol; 2016 Oct; 22(37):8294-8303. PubMed ID: 27729736 [TBL] [Abstract][Full Text] [Related]
7. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009. Younossi ZM; Otgonsuren M; Henry L; Venkatesan C; Mishra A; Erario M; Hunt S Hepatology; 2015 Dec; 62(6):1723-30. PubMed ID: 26274335 [TBL] [Abstract][Full Text] [Related]
8. Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience. Perumpail RB; Wong RJ; Ahmed A; Harrison SA Dig Dis Sci; 2015 Oct; 60(10):3142-8. PubMed ID: 26250831 [TBL] [Abstract][Full Text] [Related]
9. Liver Resection for Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma. Koh YX; Tan HJ; Liew YX; Syn N; Teo JY; Lee SY; Goh BKP; Goh GBB; Chan CY J Am Coll Surg; 2019 Nov; 229(5):467-478.e1. PubMed ID: 31398386 [TBL] [Abstract][Full Text] [Related]
10. Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis. Kodama K; Kawaguchi T; Hyogo H; Nakajima T; Ono M; Seike M; Takahashi H; Nozaki Y; Kawanaka M; Tanaka S; Imajo K; Sumida Y; Kamada Y; Fujii H; Seko Y; Takehara T; Itoh Y; Nakajima A; Masaki N; Torimura T; Saibara T; Karino Y; Chayama K; Tokushige K J Gastroenterol Hepatol; 2019 Sep; 34(9):1626-1632. PubMed ID: 30668889 [TBL] [Abstract][Full Text] [Related]
11. Hub Genes Involved in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma. Liu B; Wang X; Wu N; Liu F; Rao H Curr Med Chem; 2024 Feb; ():. PubMed ID: 38409698 [TBL] [Abstract][Full Text] [Related]
12. Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease. Bertot LC; Adams LA Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):179-187. PubMed ID: 30791782 [TBL] [Abstract][Full Text] [Related]
13. Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows. Costante F; Airola C; Santopaolo F; Gasbarrini A; Pompili M; Ponziani FR World J Gastrointest Oncol; 2022 Sep; 14(9):1622-1636. PubMed ID: 36187401 [TBL] [Abstract][Full Text] [Related]
14. Clinical Patterns and Outcome of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease. Ahn SY; Kim SB; Song IH Can J Gastroenterol Hepatol; 2020; 2020():4873875. PubMed ID: 32566546 [TBL] [Abstract][Full Text] [Related]
15. Economic growth leads to increase of obesity and associated hepatocellular carcinoma in developing countries. Seyda Seydel G; Kucukoglu O; Altinbasv A; Demir OO; Yilmaz S; Akkiz H; Otan E; Sowa JP; Canbay A Ann Hepatol; 2016; 15(5):662-72. PubMed ID: 27493104 [TBL] [Abstract][Full Text] [Related]
16. Epidemiology of non-alcoholic fatty liver disease-related hepatocellular carcinoma and its implications. Wong SW; Ting YW; Chan WK JGH Open; 2018 Oct; 2(5):235-241. PubMed ID: 30483595 [TBL] [Abstract][Full Text] [Related]
17. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis. Mohamad B; Shah V; Onyshchenko M; Elshamy M; Aucejo F; Lopez R; Hanouneh IA; Alhaddad R; Alkhouri N Hepatol Int; 2016 Jul; 10(4):632-9. PubMed ID: 26558795 [TBL] [Abstract][Full Text] [Related]
18. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease. Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986 [TBL] [Abstract][Full Text] [Related]